Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Shengyang Bioengineering Co., Ltd. is a Chinese biotechnology company specializing in the research, development, and manufacturing of veterinary pharmaceuticals and animal health products. Founded in 2006 and headquartered in Tai'an, Shandong, the company operates multiple GMP-certified production lines for injections, oral liquids, powders, and traditional Chinese medicine extracts. Its product portfolio includes a wide range of antibiotics, such as Cefquinome sulfate, as well as immune enhancers and disinfectants for livestock and poultry. The company collaborates with several academic institutions, including South China Agricultural University and Shandong Agricultural University, to advance its R&D in microbial preparations and plant extracts. Shandong Shengyang Bioengineering is recognized as a high-tech enterprise and a key player in the regional veterinary drug industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Shengyang Bioengineering.